The integrated drug development partner offering a unique combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device clients has today announced a conditional fundraising of £0.65m at 6p, including director participation of £55k.
04 Jul 2018
Placing and investment in biostatistics offering
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Placing and investment in biostatistics offering
hVIVO plc (HVO:LON) | 28.6 0 0.4% | Mkt Cap: 194.6m
- Published:
04 Jul 2018 -
Author:
Derren Nathan -
Pages:
6
The integrated drug development partner offering a unique combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device clients has today announced a conditional fundraising of £0.65m at 6p, including director participation of £55k.